Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Romidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
- Status
- COMPLETED
- Phase
- PHASE2
LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab
- Status
- COMPLETED
- Phase
- PHASE1
Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Mass Balance, Pharmacokinetics and Metabolism Study of IXAZOMIB
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Rituximab + GM-CSF in Patients With Follicular B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
- Status
- COMPLETED
- Phase
- N/A
Thromboelastography, Platelet Function and Platelet Recovery in Haemato-oncologic Patients With Thrombocytopenia
- Status
- COMPLETED
- Phase
- N/A
Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- COMPLETED
- Phase
- PHASE1
Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy
- Status
- SUSPENDED
- Phase
- N/A
Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative
- Status
- COMPLETED
- Phase
- PHASE1